SIERRA ONCOLOGY Revenue, Profits - SRRA Annual Income Statement

Add to My Stocks
$1.83 $0 (0%) SRRA stock closing price Sep 18, 2018 (Closing)

Financial analysis of SIERRA ONCOLOGY involves more than just checking the SIERRA ONCOLOGY stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the SRRA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. The operating expenses as shown in the SIERRA ONCOLOGY profit and loss statement for 2017 total to $42.61M. This line item shows that the operating expenses has increased compared with last year. Also check: SIERRA ONCOLOGY assets and SIERRA ONCOLOGY free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
SIERRA ONCOLOGY Revenues or Net Sales
Cost Of Goods Sold (COGS)-----
Research & Development Expense30.15M-26.35M19.07M2.84M
Selling General & Admin Expense12.46M-9.47M3.5M1.16M
Income Before Depreciation Depletion Amortization-42.61M--35.82M-22.57M-4M
Depreciation Depletion Amortization-----
Non Operating Income---17.37M-1.29M-2.82M
Interest Expense-----
Provision for Income Taxes-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-42.01M--53.26M-23.87M-6.83M
Extraordinary Items & Discontinued Operations-----
SIERRA ONCOLOGY Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS49.9M30.24M14.4M--
Average Shares used to compute Basic EPS49.9M30.24M14.4M--
Income Before Nonrecurring Items-42.02M-47.87M-37.13M--
Income from Nonrecurring Items---16.13M--
SIERRA ONCOLOGY Earnings Per Share Basic Net
SIERRA ONCOLOGY Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.84-1.58-30.35--
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing SIERRA ONCOLOGY stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: SIERRA ONCOLOGY revenue chart implies that the company is growing. It has not been the case with SIERRA ONCOLOGY. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like SIERRA ONCOLOGY try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the SRRA income statement, one can check the SIERRA ONCOLOGY historical stock prices to check how the price has moved with time.

SIERRA ONCOLOGY Income Statement - Key Financial Ratios